Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164502 · ClinicalTrials.gov registry record · Phase 2
Limb Loss Self-Management Program
A Phase 2 study of Congenital or Acquired Limb Deficiency, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT00164502 is a Phase 2 study of Congenital or Acquired Limb Deficiency that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00164502, a Phase 2 study of Congenital or Acquired Limb Deficiency, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the project is to develop and test the efficacy of a community-based self-management intervention for reducing pain, depression, and improving self-efficacy and function in person with limb loss
Conditions Studied
Interventions
- BEHAVIORAL Community-based eight session group self-management program
Study Locations (1)
Washington
- Puget Sound Health Services - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2003-10 |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00164502
The ClinicalTrials.gov registry entry for NCT00164502 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital or Acquired Limb Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Community-based eight session group self-management program is the first listed.
NCT00164502 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00164502 about?
NCT00164502 is a clinical study titled "Limb Loss Self-Management Program". The goal of the project is to develop and test the efficacy of a community-based self-management intervention for reducing pain, depression, and improving self-efficacy and function in person with limb loss
What is the current status of trial NCT00164502?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 500 participants. The study started on 2003-10. Estimated completion is 2005-06.
What conditions does trial NCT00164502 study?
This clinical trial studies the following conditions: Congenital or Acquired Limb Deficiency.
What interventions are being tested in trial NCT00164502?
The interventions under investigation include: Community-based eight session group self-management program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164502?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00164502 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.